Log in Book a Demo

US Pharma & Biotech Neuroscience - PPC Market Share Analysis September 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Neuroscience category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Neuroscience – US

Google AI Overview visibility for Pharma & Biotech Neuroscience US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 72.0140876073
27.9859123927
72%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 32
68
32%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 8%
Transactional 4%
Navigational 0%
Seasonal 0%
Local 0%
Problem Solving 33%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
vraylar.com 25.66
caplyta.com 19.11
rexulti.com 16.6
rexultihcp.com 7.86
caplytahcp.com 5.16
vraylarhcp.com 4.89
vyepti.com 2.98
nurtec.com 2.8
spravatohcp.com 1.58
cobenfy.com 1.14
others 12.22
  • vraylar.com - 25.66%
  • caplyta.com - 19.11%
  • rexulti.com - 16.6%
  • rexultihcp.com - 7.86%
  • caplytahcp.com - 5.16%
  • vraylarhcp.com - 4.89%
  • vyepti.com - 2.98%
  • nurtec.com - 2.8%
  • spravatohcp.com - 1.58%
  • cobenfy.com - 1.14%
  • others - 12.22%

Copyright © Adthena. All rights reserved.

In the competitive landscape, vraylar.com leads with 25.66% click share, followed by caplyta.com at 19.11%. ‘Others’ collectively hold 12.22%, showcasing diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date caplyta.com vraylar.com rexulti.com caplytahcp.com rexultihcp.com vraylarhcp.com nurtec.com vyepti.com spravatohcp.com goodrx.com
2026/09/01 26.4% 25.41% 15.26% 4.23% 7.35% 5.46% 3.25% 2.5% 0.44% 0.94%
2026/09/02 17.01% 32.11% 17.48% 2.64% 8.13% 7.54% 2.18% 3.68% 0.62% 1.33%
2026/09/03 23.68% 28.96% 16.34% 3.8% 7.29% 6.52% 2.22% 2.29% 0.65% 1%
2026/09/04 22.18% 27.86% 15.9% 4.69% 7.91% 6.75% 2.05% 2.84% 0.63% 1.88%
2026/09/05 13.77% 32.65% 16.86% 2.95% 8.35% 6.07% 2.53% 2.51% 0.62% 1.47%
2026/09/06 19.8% 26.42% 16.5% 4.94% 8.91% 6.9% 2.18% 3.23% 0.96% 1.1%
2026/09/07 22.16% 22.24% 15.64% 4.8% 9.12% 5.81% 2.3% 2.94% 0.65% 1.32%
2026/09/08 13.31% 28.41% 17.43% 2.93% 9.21% 4.09% 2.74% 3.63% 0.98% 1.52%
2026/09/09 22.36% 28.76% 12.76% 4.96% 6.84% 4.29% 1.94% 2.82% 0.95% 0.72%
2026/09/10 22.18% 26.51% 15.42% 6.2% 8.11% 3.26% 2.27% 3.1% 0.7% 1.35%
2026/09/11 25.05% 24.19% 14.22% 6.66% 9.38% 4.4% 1.84% 2.22% 1.07% 1.51%
2026/09/12 19.73% 24.63% 14.24% 5% 9.07% 8.49% 1.75% 3.02% 1.61% 0.82%
2026/09/13 21.07% 18.95% 15.07% 5.58% 8.66% 7.5% 1.48% 2.28% 1.52% 1.01%
2026/09/14 25.59% 21.54% 14.13% 6.03% 8.76% 6.8% 1.35% 2.44% 1.43% 0.73%
2026/09/15 18.94% 21.59% 14.38% 6.7% 8.7% 8.64% 1.98% 2.37% 1.13% 0.87%
2026/09/16 24.15% 21.55% 12.14% 8.66% 7.12% 6.53% 1.43% 2.53% 1.74% 1.27%
2026/09/17 27.04% 19.07% 11.67% 8.93% 7.28% 6.83% 1.45% 2.49% 1.39% 0.88%
2026/09/18 29.02% 23.07% 11.17% 7.47% 7.09% 5.79% 2.01% 1.41% 1.84% 1.63%
2026/09/19 26.65% 24.57% 11.46% 7.82% 7.47% 3.88% 1.84% 2.12% 1.73% 1.25%
2026/09/20 28.34% 24.94% 11.71% 7.9% 7.47% 3.7% 1.2% 1.55% 1.16% 0.96%
2026/09/21 25.75% 24.94% 11.58% 9.29% 7.28% 4.4% 1.56% 1.28% 1.24% 1.01%
2026/09/22 27.04% 26.16% 12.13% 7.39% 6.53% 4.94% 1.41% 1.15% 1.36% 0.84%
2026/09/23 22.7% 30.16% 13.55% 6.77% 7.5% 3.72% 1.38% 1.45% 1.67% 0.95%
2026/09/24 16.31% 33.21% 12.35% 5.24% 7.37% 5.76% 1.49% 1.85% 1.11% 1.28%
2026/09/25 31.42% 24.36% 10.38% 8.39% 6.43% 3.67% 1.5% 1.29% 1% 0.7%
2026/09/26 27.51% 25.8% 10.25% 7.2% 7.33% 3.91% 1.28% 1.35% 2.32% 1.31%
2026/09/27 26.29% 25.85% 10.15% 6.86% 6.71% 4.9% 1.29% 2.01% 1.22% 1.04%
2026/09/28 26.99% 26.22% 12.55% 6.11% 6.27% 5.29% 1.56% 2.49% 1.39% 0.62%
2026/09/29 29.04% 24.16% 10.65% 7.57% 6.13% 5.1% 1.57% 2.35% 1.37% 1.16%
2026/09/30 31.15% 23.89% 11.23% 7.3% 6.53% 4.45% 1.94% 1.64% 1.46% 0.97%
  • caplyta.com
  • vraylar.com
  • rexulti.com
  • caplytahcp.com
  • rexultihcp.com
  • vraylarhcp.com
  • nurtec.com
  • vyepti.com
  • spravatohcp.com
  • goodrx.com

Copyright © Adthena. All rights reserved.

In September 2026, Caplyta.com saw fluctuating PPC spend, peaking at 31.42% on the 25th. Vraylar.com led early, but dipped, finishing at 23.89%. Rexulti.com maintained a steady low, while Caplytahcp.com and Rexultihcp.com showed moderate activity. Nurtec.com and Vyepti.com had minimal presence, with Spravatohcp.com and Goodrx.com trailing.

Market Exposure

Competitor Count for US Pharma & Biotech Neuroscience

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/09/01 68
2026/09/02 69
2026/09/03 69
2026/09/04 73
2026/09/05 75
2026/09/06 77
2026/09/07 75
2026/09/08 83
2026/09/09 82
2026/09/10 80
2026/09/11 85
2026/09/12 82
2026/09/13 86
2026/09/14 80
2026/09/15 87
2026/09/16 84
2026/09/17 86
2026/09/18 81
2026/09/19 82
2026/09/20 84
2026/09/21 90
2026/09/22 87
2026/09/23 84
2026/09/24 83
2026/09/25 82
2026/09/26 84
2026/09/27 81
2026/09/28 83
2026/09/29 80
2026/09/30 76

Copyright © Adthena. All rights reserved.

September saw a dynamic rise in distinct advertisers, peaking at 90 on the 21st. The month concluded with a slight dip to 76, reflecting a vibrant yet fluctuating advertising landscape.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
caplyta.com 5.39%
caplytahcp.com 1.85%
vraylar.com 1.28%
cobenfy.com 0.56%
spravatohcp.com 0.38%
nurtec.com -0.55%
vraylarhcp.com -1.1%
rexultihcp.com -1.17%
vyepti.com -1.19%
rexulti.com -4.51%

Copyright © Adthena. All rights reserved.

Caplyta.com surged with a 5.39% increase, while rexulti.com dropped by 4.51%. Caplytahcp.com rose 1.85%, and vraylar.com gained 1.28%. Vyepti.com, rexultihcp.com, and vraylarhcp.com saw declines.

Campaign Efficiency

US Pharma & Biotech Neuroscience Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date vraylar.com caplyta.com rexulti.com rexultihcp.com caplytahcp.com vraylarhcp.com vyepti.com goodrx.com nurtec.com spravatohcp.com
2026/09/01 16.82% 11.24% 13.21% 13.21% 5.28% 6.87% 6.89% 4.21% 5.57% 0.93%
2026/09/02 18.79% 9.57% 13.94% 13.71% 3.12% 8.76% 10.16% 5.52% 2.62% 1.24%
2026/09/03 19.01% 9.94% 14.31% 13.6% 4.69% 8.35% 6.97% 4.75% 3.43% 1.26%
2026/09/04 16.34% 13.58% 13% 13.28% 5.3% 7.89% 7.25% 7.97% 2.54% 1.21%
2026/09/05 18.94% 9.29% 14.18% 14.54% 3.16% 6.87% 5.83% 6.1% 3.36% 1.43%
2026/09/06 14.7% 12.54% 15.36% 14.2% 5.22% 7.57% 8.07% 4.43% 2.5% 1.76%
2026/09/07 11.89% 13.2% 12.97% 14.32% 5.2% 5.92% 7.32% 5.13% 2.9% 1.57%
2026/09/08 14.62% 8.23% 13.18% 13.35% 3.08% 4.14% 8.57% 5.75% 3.42% 1.97%
2026/09/09 16.93% 11.41% 11.78% 11.45% 5.93% 5.04% 7.59% 2.88% 2.55% 2.03%
2026/09/10 15.11% 11.79% 13.33% 13.1% 7.27% 3.7% 7.5% 5.46% 3.22% 1.52%
2026/09/11 14.39% 11.3% 13.42% 15.98% 8.11% 5.2% 5.76% 6.35% 2.38% 2.02%
2026/09/12 13.69% 9.67% 14.23% 14.78% 5.35% 8.93% 7.38% 3.17% 2.23% 2.89%
2026/09/13 9.99% 11.79% 14.75% 13.82% 5.85% 7.78% 5.29% 3.84% 1.62% 2.55%
2026/09/14 12.08% 12.67% 15.3% 15.11% 6.96% 7.34% 6.11% 2.87% 1.54% 2.69%
2026/09/15 11.66% 9.75% 13.39% 13.85% 7.62% 9.27% 5.61% 3.27% 2.29% 2.04%
2026/09/16 12.32% 10.42% 12.47% 11.87% 9.86% 7.31% 6.63% 4.14% 1.8% 3.13%
2026/09/17 11.2% 10.39% 11.8% 12.17% 10.47% 7.91% 6.73% 3.49% 2.18% 2.6%
2026/09/18 13.81% 12.17% 12.89% 12.66% 8.95% 6.99% 3.97% 6.16% 3.04% 3.59%
2026/09/19 14.44% 11.44% 12.72% 12.49% 9.4% 4.54% 6.12% 5.03% 2.55% 3.25%
2026/09/20 15.67% 12.87% 12.48% 13.42% 9.89% 4.66% 4.43% 4.17% 1.62% 2.29%
2026/09/21 15.15% 10.84% 11.99% 13.06% 11.63% 5.37% 3.5% 4.48% 2.15% 2.31%
2026/09/22 16.75% 12.59% 12.79% 12.25% 9.51% 6.32% 3.39% 3.75% 1.83% 2.55%
2026/09/23 19% 10.72% 13.98% 13.21% 8.42% 4.7% 3.92% 4.35% 1.72% 2.9%
2026/09/24 18.68% 9.13% 11.92% 11.94% 6.3% 6.44% 4.52% 4.96% 1.82% 1.94%
2026/09/25 15.83% 14.42% 11.45% 12.17% 10.98% 4.76% 3.56% 3.29% 2.26% 2.45%
2026/09/26 15.97% 12.83% 10.69% 12.56% 9.04% 4.76% 3.61% 5.62% 1.61% 3.78%
2026/09/27 15.88% 12.07% 10.53% 11.53% 8.14% 5.86% 5.26% 4.29% 1.58% 2%
2026/09/28 16.36% 12.74% 13.12% 11.02% 8.01% 6.47% 6.25% 2.66% 2.01% 2.54%
2026/09/29 14.53% 13.83% 11.15% 10.5% 9.07% 6.1% 6.03% 4.67% 2.32% 2.45%
2026/09/30 14.8% 14.58% 12.88% 11.85% 9.31% 5.51% 4.34% 4.23% 3.19% 2.6%
  • vraylar.com
  • caplyta.com
  • rexulti.com
  • rexultihcp.com
  • caplytahcp.com
  • vraylarhcp.com
  • vyepti.com
  • goodrx.com
  • nurtec.com
  • spravatohcp.com

Copyright © Adthena. All rights reserved.

In September 2026, Vraylar.com led with fluctuating impressions, peaking mid-month. Caplyta.com and Rexulti.com followed, showing steady gains. By month’s end, Vraylar.com maintained dominance, while Caplyta.com closed strong.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience - Last month
  1. 1
    CAPLYTA® (lumateperone) - Official Patient Website https://www.caplyta.com/

    Visit the Official Site for Product & Safety Information, Including Boxed WARNINGS. Find Out Information On CAPLYTA® & How To Talk To Your Doctor About Add-On Therapy Option.

  2. 2
    REXULTI® (brexpiprazole) - FDA-Approved Treatment Option https://www.rexulti.com/

    REXULTI® (brexpiprazole) Important Safety, Prescribing Info & Boxed Warning

  3. 3
    REXULTI® (brexpiprazole) - Healthcare Professional Site https://www.rexultihcp.com/

    REXULTI® (brexpiprazole) Important Safety, Prescribing Info & BOXED WARNING. View REXULTI® Safety & Prescribing Info, & BOXED WARNING. Visit The Official HCP Website. Official Physician Site.

  4. 4
    VRAYLAR® (cariprazine) - Medication Information https://www.vraylar.com/

    See VRAYLAR® (cariprazine) Full Prescribing Information, Including Boxed Warnings.

  5. 5
    VRAYLAR® (cariprazine) | FDA-Approved Treatment http://www.vraylarhcp.com

    View Safety, Prescribing Info, and Boxed Warnings. Get More Information. Learn About VRAYLAR® and See if It's The Right Treatment for Your Patients.

Copyright © Adthena. All rights reserved.

In the competitive landscape of pharmaceuticals, CAPLYTA®, REXULTI®, and VRAYLAR® dominate Google’s PPC ads. Their messaging focuses on safety, prescribing information, and boxed warnings, targeting both patients and healthcare professionals. Each ad emphasizes official resources, ensuring trust and informed decision-making.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.